Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AMGN | BMY | GILD | VRTX |
| Company | Protagonist Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 36.80 | 260.79 | 56.36 | 90.19 | 406.17 |
| High | 37.64 | 264.79 | 56.36 | 91.43 | 412.69 |
| Low | 36.40 | 260.55 | 55.63 | 89.16 | 405.17 |
| Last | 36.52 | 262.12 | 56.20 | 89.42 | 408.19 |
| Change | -1.10 | -2.09 | -0.61 | +0.28 | -3.92 |
| % Change | -2.92% | -0.79% | -1.07% | +0.31% | -0.95% |
| Volume | 112,024 | 624,448 | 3,315,811 | 2,554,024 | 412,897 |
| 20-Day Average Volume | 647,069 | 3,579,878 | 11,484,497 | 6,147,457 | 1,929,769 |
| Previous Close | 37.62 | 264.21 | 56.81 | 89.14 | 412.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.48 | 263.78 | 56.81 | 92.00 | 422.73 |
| 20-Day Raw Stochastic | 3.21% | 38.32% | 25.53% | 10.18% | 32.46% |
| 20-Day Relative Strength | 37.82% | 37.46% | 46.61% | 45.14% | 38.57% |
| Weighted Alpha | +24.33 | -18.69 | +16.42 | +12.38 | -11.16 |
| Today's Opinion | 40% Sell | 100% Sell | 40% Buy | 56% Buy | 88% Sell |
| Previous Opinion | 40% Sell | 88% Sell | 40% Buy | 56% Buy | 88% Sell |
| Last Month's Opinion | 8% Buy | 72% Sell | 100% Buy | 88% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.70% since 01/02/25 | +1.09% since 01/02/25 | -1.51% since 01/02/25 | -2.51% since 01/02/25 | +0.83% since 01/02/25 |
| Low | 36.58 on 01/10/25 | 257.05 on 01/06/25 | 55.63 on 01/10/25 | 89.00 on 01/08/25 | 399.00 on 01/06/25 |
| High | 40.16 on 01/03/25 | 265.21 on 01/07/25 | 57.67 on 01/07/25 | 92.34 on 01/03/25 | 412.54 on 01/10/25 |
| 1-Month | |||||
| %Chg | -11.63% since 12/10/24 | -4.95% since 12/10/24 | -3.76% since 12/10/24 | -2.99% since 12/10/24 | -12.81% since 12/10/24 |
| Low | 36.58 on 01/10/25 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.00 on 01/08/25 | 377.85 on 12/19/24 |
| High | 42.19 on 12/11/24 | 276.28 on 12/11/24 | 58.54 on 12/18/24 | 94.65 on 12/11/24 | 474.18 on 12/17/24 |
| 3-Month | |||||
| %Chg | -15.67% since 10/10/24 | -18.35% since 10/10/24 | +6.75% since 10/10/24 | +5.79% since 10/10/24 | -14.08% since 10/10/24 |
| Low | 33.31 on 11/19/24 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
| High | 48.89 on 10/28/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +5.69% since 07/10/24 | -18.52% since 07/10/24 | +36.03% since 07/10/24 | +30.29% since 07/10/24 | -16.78% since 07/10/24 |
| Low | 32.50 on 08/05/24 | 253.30 on 12/19/24 | 39.92 on 07/15/24 | 68.14 on 07/11/24 | 377.85 on 12/19/24 |
| High | 48.89 on 10/28/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,242,076 | 142,021,584 | 115,220,736 | 111,092,152 | 106,130,272 |
| Shares Outstanding, K | 59,598 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 60,000,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -78,960,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,680,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -33,210,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 2.23 | 0.56 | 0.45 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 11/07/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 02/25/25 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 14.45 | 13.63 | 48.84 | 20.46 | 0.00 |